HRT Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

HRT Financial’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-32,868	Closed	-$10.4M	–	3335
2023 Q4	$10.4M	Buy	+32,868	New	+$6.39M	0.08%	158
2023 Q3	–	Sell	-80,848	Closed	-$17.5M	–	3320
2023 Q2	$17.5M	Buy	+80,848	New	+$17.3M	0.16%	79
2022 Q4	–	Sell	-8,796	Closed	-$1.98M	–	3395
2022 Q3	$1.98M	Buy	+8,796	New	+$1.78M	0.02%	603
2022 Q1	–	Sell	-8,499	Closed	-$1.11M	–	4063
2021 Q4	$1.11M	Buy	+8,499	New	+$1.1M	0.01%	1017

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

HRT Financial's KRTX Position: Q1 2024 in Review

HRT Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 32,868 shares — an estimated $10.4M sold.

HRT Financial first reported a position in KRTX in Q4 2021 and held it in 4 quarters. The position peaked at $17.5M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

HRT Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 32,868 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $10.4M.
HRT Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
HRT Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $17.5M in Q2 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.